In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is tightening its belt in an effort to get the most out of its cancer med. On ...

Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. The pharma giant announced Monday that sigvotatug vedotin, the first new ADC to read out pivotal data following its ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

Hyderabad-based infrastructure major Megha Engineering and Infrastructures Limited (MEIL) on Wednesday entered into a strategic partnership with global technology company Analog to deploy “Physical ...

Alert Gedatolisib Combo Approved for Advanced Breast Cancer Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

The game is on for TROP2 antibody-drug conjugates in first-line triple-negative breast cancer. Less than a month after an approval for Daiichi Sankyo and AstraZeneca’s Datroway for front-line TNBC ...

Integrin β6 is expressed in ~90% of NSCLC and correlates with poor prognosis, supporting development of a selective, rapidly internalizing ADC designed to reduce off-target integrin binding.

SHAREit is a popular application that allows you to easily transfer photos, videos, and files between iPhone, Android, and a Windows PC or Mac without an Internet connection. 2] Using Hotspot. The ...